Renovaro Cube audited: €2.1M net loss post-acquisition, going concern noted

Lunai Bioworks Inc.

Successor period (Aug 24–Dec 31, 2023) net loss of €2,100,579, no revenue generated.
Accumulated deficit of €2,100,579; cash only €114,520 at Dec 31, 2023.
Auditor includes going-concern explanatory paragraph citing negative operating cash flows and deficit.
Predecessor (Grace Systems) net loss €129,572 for Jan 1–Aug 23, 2023 and €623,982 for FY 2022.
Acquisition of Grace Systems by Renovaro Cube treated as asset acquisition; company in development stage.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.